U.S. Physical Therapy, Inc. (NYSE:USPH) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• U.S. Physical Therapy, Inc. has received a consensus rating of "Moderate Buy" from eight brokerage firms, with an average twelve-month target price of $110.25.
• The company recently reported quarterly earnings of $0.90 EPS and a revenue of $140.66 million, with a net margin of 5.05%.
• U.S. Physical Therapy announced a quarterly dividend of $0.45, resulting in an annualized dividend yield of 2.0% and a payout ratio of 78.60%.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight ratings firms that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $110.25.

Several equities analysts have recently commented on the stock. Zacks Research upgraded shares of U.S. Physical Therapy to a "hold" rating in a report on Friday, August 8th. Wall Street Zen lowered shares of U.S. Physical Therapy from a "buy" rating to a "hold" rating in a report on Sunday, September 21st. Weiss Ratings reiterated a "hold (c)" rating on shares of U.S. Physical Therapy in a report on Wednesday, October 8th. Barrington Research increased their target price on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. Finally, JPMorgan Chase & Co. initiated coverage on shares of U.S. Physical Therapy in a research report on Thursday, September 18th. They issued an "overweight" rating and a $110.00 price objective on the stock.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $88.64 on Tuesday. The firm's 50 day moving average price is $83.98 and its 200-day moving average price is $77.53. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $101.19. The firm has a market cap of $1.35 billion, a P/E ratio of 38.71, a P/E/G ratio of 4.40 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm had revenue of $140.66 million for the quarter. As a group, equities research analysts predict that U.S. Physical Therapy will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Shareholders of record on Friday, August 22nd were given a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.0%. U.S. Physical Therapy's dividend payout ratio is currently 78.60%.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 763 shares of the stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $84.97, for a total value of $64,832.11. Following the sale, the chief operating officer directly owned 21,483 shares of the company's stock, valued at approximately $1,825,410.51. This represents a 3.43% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Nancy Ham sold 600 shares of the stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $81.71, for a total transaction of $49,026.00. Following the completion of the sale, the director directly owned 1,994 shares in the company, valued at approximately $162,929.74. This represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,853 shares of company stock worth $581,406. Corporate insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 8.9% in the 2nd quarter. Copeland Capital Management LLC now owns 888,735 shares of the company's stock valued at $69,499,000 after buying an additional 72,463 shares during the last quarter. Geode Capital Management LLC grew its position in shares of U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company's stock valued at $27,602,000 after buying an additional 4,306 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 9.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company's stock valued at $27,070,000 after buying an additional 29,671 shares during the last quarter. Bahl & Gaynor Inc. grew its position in shares of U.S. Physical Therapy by 32.6% in the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company's stock valued at $24,964,000 after buying an additional 84,878 shares during the last quarter. Finally, GW&K Investment Management LLC grew its position in shares of U.S. Physical Therapy by 8.9% in the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company's stock valued at $24,920,000 after buying an additional 28,203 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.